UY27523A1 - Tetra-, penta-, hexa-y heptapéptidos con actividad antiangiogénica - Google Patents
Tetra-, penta-, hexa-y heptapéptidos con actividad antiangiogénicaInfo
- Publication number
- UY27523A1 UY27523A1 UY27523A UY27523A UY27523A1 UY 27523 A1 UY27523 A1 UY 27523A1 UY 27523 A UY27523 A UY 27523A UY 27523 A UY27523 A UY 27523A UY 27523 A1 UY27523 A1 UY 27523A1
- Authority
- UY
- Uruguay
- Prior art keywords
- antiangiogen
- heptapeptides
- hexa
- penta
- tetra
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Los compuestos de fórmula (SEQ ID NO:2) y (SEQ ID NO:3), que son útiles para el tratamiento de condiciones causadas por la angiogénesis o que son exacerbadas por la misma. También se describen composiciones farmacéuticas que comprenden tales compuestos, métodos de tratamiento en los que se los utiliza y métodos para inhibir la angiogénesis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/000,540 US20030119745A1 (en) | 2001-10-31 | 2001-10-31 | HEXA- and heptapeptides having antiangiogenic activity |
US10/000,711 US20030105025A1 (en) | 2001-10-31 | 2001-10-31 | Tri-and tetrapeptides having antiangiogenic activity |
US10/263,811 US20030105022A1 (en) | 2001-10-31 | 2002-10-04 | Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27523A1 true UY27523A1 (es) | 2003-05-30 |
Family
ID=32659830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27523A UY27523A1 (es) | 2001-10-31 | 2002-10-30 | Tetra-, penta-, hexa-y heptapéptidos con actividad antiangiogénica |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1451209A4 (es) |
JP (1) | JP2005512980A (es) |
CA (1) | CA2466152A1 (es) |
MX (1) | MXPA04004135A (es) |
UY (1) | UY27523A1 (es) |
WO (1) | WO2003037266A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030125260A1 (en) * | 2001-10-31 | 2003-07-03 | Fortuna Haviv | Tetra-and pentapeptides having antiangiogenic activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780426A (en) * | 1995-06-07 | 1998-07-14 | Ixsys, Incorporated | Fivemer cyclic peptide inhibitors of diseases involving αv β3 |
US5932545A (en) * | 1997-03-17 | 1999-08-03 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
HUP0102579A3 (en) * | 1998-05-22 | 2002-02-28 | Abbott Lab | Peptide antiangiogenic drugs, pharmaceutical compositions comprising thereof and their use |
-
2002
- 2002-10-30 EP EP02789322A patent/EP1451209A4/en not_active Withdrawn
- 2002-10-30 UY UY27523A patent/UY27523A1/es not_active Application Discontinuation
- 2002-10-30 JP JP2003539612A patent/JP2005512980A/ja active Pending
- 2002-10-30 CA CA002466152A patent/CA2466152A1/en not_active Abandoned
- 2002-10-30 MX MXPA04004135A patent/MXPA04004135A/es unknown
- 2002-10-30 WO PCT/US2002/034760 patent/WO2003037266A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2003037266A3 (en) | 2003-12-11 |
JP2005512980A (ja) | 2005-05-12 |
WO2003037266A2 (en) | 2003-05-08 |
EP1451209A2 (en) | 2004-09-01 |
EP1451209A4 (en) | 2009-06-03 |
MXPA04004135A (es) | 2004-07-08 |
CA2466152A1 (en) | 2003-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE263157T1 (de) | Nematizide trifluorbutene | |
WO2003029264A3 (en) | 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof | |
BR0307833A (pt) | Sìntese controlada de ziprasidona e suas composições | |
CR6592A (es) | Compuestos para el tratamiento de la isquemia | |
ES2154167B1 (es) | Aminoderivados ciclicos antagonistas del receptor ccr-3. | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
DE60112609D1 (en) | Pyrazolopyridine | |
ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
BR0112030A (pt) | Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor | |
BR0213207A (pt) | remodelagem e glicoconjugação de peptìdeos | |
DOP2002000456A (es) | Inhibidores de la alquin-aril fosfodiesterasa-4'' | |
AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
DE60324544D1 (de) | Muskarin antagonisten | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
UY27232A1 (es) | Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos | |
MXPA02012752A (es) | Agentes herbicidas. | |
SE9901077D0 (sv) | Novel use | |
ECSP034598A (es) | Compuesto lactamico | |
TNSN03065A1 (en) | BIOPESTICIDE COMPOSITIONS | |
MXPA03008801A (es) | Aril oxima-piperazinas utiles como antagonistas de ccr5. | |
DE60201074D1 (en) | Pyrazolopyridinderivate | |
UY27394A1 (es) | Pedidos con actividad anti- angiogéna. | |
SE9904128D0 (sv) | Novel compounds | |
NO20002408D0 (no) | 5-HT1F antagonister | |
GB0103045D0 (en) | Organic Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150126 |